ArticlePolymers2018
Poly(3-hydroxybutyrate) Modified by Nanocellulose and Plasma Treatment for Packaging Applications.
Article in Polymers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Article
- Improving Poly(3-Hydroxybutyrate) Properties Using Nanocellulose in Biomedical Applications: Thermal, Mechanical and Biological Studies.International journal of molecular sciences · 2025Article
- Poly(3-hydroxybutyrate)/Clay/Essential Oils Bionanocomposites Incorporating Biochar: Thermo-Mechanical and Antioxidant Properties.Polymers · 2025Article
- Tailoring the Conductivity and Flexibility of Natural Poly(3-hydroxybutyrate-Materials (Basel, Switzerland) · 2025Article
- Development of Polyhydroxybutyrate-Based Packaging Films and Methods to Their Ultrasonic Welding.Materials (Basel, Switzerland) · 2023Article
- Nanocellulose Sponges Containing Antibacterial Basil Extract.International journal of molecular sciences · 2023Article
- Opposite Roles of Bacterial Cellulose Nanofibers and Foaming Agent in Polyhydroxyalkanoate-Based Materials.Polymers · 2022Article
- Cost-Effective Synthesis of Bacterial Cellulose and Its Applications in the Food and Environmental Sectors.Gels (Basel, Switzerland) · 2022Review
- Article
- Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery.International journal of molecular sciences · 2020Article
- Article
- The Application of (+)-Catechin and Polydatin as Functional Additives for Biodegradable Polyesters.International journal of molecular sciences · 2020Article
- Effect of Beta Radiation on the Quality of the Bonded Joint for Difficult to Bond Polyolefins.Polymers · 2019Article
- Article
- Bio-Based Polymers with Antimicrobial Properties towards Sustainable Development.Materials (Basel, Switzerland) · 2019Review
- Oxygen-Scavenging Multilayered Biopapers Containing Palladium Nanoparticles Obtained by the Electrospinning Coating Technique.Nanomaterials (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this work, a new eco-friendly method for the treatment of poly(3-hydroxybutyrate) (PHB) as a candidate for food packaging applications is proposed. Poly(3-hydroxybutyrate) was modified by bacterial cellulose nanofibers (BC) using a melt compounding technique and by plasma treatment or zinc oxide (ZnO) nanoparticle plasma coating for better properties and antibacterial activity. Plasma treatment preserved the thermal stability, crystallinity and melting behavior of PHB‒BC nanocomposites, regardless of the amount of BC nanofibers. However, a remarkable increase of stiffness and strength and an increase of the antibacterial activity were noted. After the plasma treatment, the storage modulus of PHB having 2 wt % BC increases by 19% at room temperature and by 43% at 100 °C. The tensile strength increases as well by 21%. In addition, plasma treatment also inhibits the growth of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.